Generic antifungal drug put to the test in healthy volunteers
NCT ID NCT06977490
First seen Jan 04, 2026 · Last updated May 21, 2026 · Updated 22 times
Summary
This study tested whether a new version of the antifungal medicine amphotericin B liposome works the same as the standard version. 42 healthy adults received a single dose of each formulation in a random order. The goal was to see if the two versions are bioequivalent, meaning they produce similar levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE FUNGAL INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jinan Central Hospital, No.105, Jiefang Road,
Jinan, Shandong, China
Conditions
Explore the condition pages connected to this study.